Brief: Shilpa Medicare Says CDMO Customer Receives Fast-Track Designation For Its Investigational Drug Candidate
16/10/2024 10:07
Oct 16 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* CDMO CUSTOMER RECEIVES FAST-TRACK DESIGNATION FOR ITS
INVESTIGATIONAL DRUG CANDIDATE
Source text for Eikon: ID:nBSE190LqL
Further company coverage: SHME.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026